Meitu is looking to achieve a pricey IPO valuation for an unprofitable internet company selling inexpensive phones.
With prices high for emerging-market debt, any uptick in supply or deterioration in demand could tip the balance in an unpleasant way.
Investors are favoring further-flung, more exciting destinations than Europe for their cash. But steady growth remains a reassuring factor.
Big banks have long complained about the costs of holding large pools of inactive deposits, especially in countries where interest rates have turned negative. Increasingly, they are charging customers to look after their cash.
Concordia CEO’s margin call is the latest stumble in the company’s bad year.
Retailers with a significant back-to-school business face easy comparisons, but that may already be priced into their shares.
Easing financial conditions could give Valeant’s new finance chief an assist.
Shares of the chip-gear maker are running high, but probably aren’t at a peak.
Pfizer’s $14 billion acquisition shows quality midsize biotechs are in short supply.